4-isopropylphenyl glucitol compounds as SGLT1 inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 18, 2013
Grant Date -
Dec 15, 2011
app pub date -
Feb 23, 2010
filing date -
Feb 23, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides 4-isopropylphenyl glucitol compounds which have no tendency to accumulate in the body and which inhibit SGLT1 activity to suppress postprandial hyperglycemia (or impaired glucose tolerance) through suppression of glucose absorption in the small intestine, whereby the compounds, for example, can suppress the onset of diabetes and metabolic syndrome or can treat these diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully